Investment and M&A transaction comps
Vitamins And Supplements Investment & M&A Transaction Comps
Reviewed transaction comps tagged vitamins and supplements, including disclosed, estimated and rumored values where source notes or calculation basis are available.
13
Reviewed transactions
7
With price data
3.4x
Median EV or valuation / revenue
17.9x
Median EV or valuation / EBITDA
Sortable transaction comps
Vitamins And Supplements transaction table
Rows with reported value
7 / 13
Acquisition value, USD
USD 13B
Investment capital, USD
-
Median EV or valuation / revenue
3.4x
Select up to 12 rows across filters and pages, then share or export the set.
Selected comparison set
Saved in this browser only. Nothing is written to FundComb data.
Choose transactions from the table to build a quick comparison set.
13 shown of 13 matching transactions. Click any transaction row for more detail.
| Select for comparison | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Thorne HealthTech Control | 2023-08-28 | L Catterton | USD 681M Enterprise Value | 681 | 3.7x | 21.2x | - | Estimated 2 sources | ||
| Blackmores Control (100%) | 2023-04-26 | Kirin | USD 1.2B Enterprise Value | 1,241 | 2.9x | 23.1x | Australia | Estimated 3 sources | ||
| Youtheory Control (95%) | 2022-06-01 | Jamieson Wellness Inc. | Undisclosed | Undisclosed | 1.8x | 10.0x | North America | Confirmed 1 source | ||
| Uqora Control | 2021-07-08 | Pharmavite | Undisclosed | Undisclosed | - | - | United States | Confirmed 1 source | ||
| 2021-04-30 | Nestlé | USD 5.8B Consideration | 5,750 | 3.1x | 16.8x | - | Confirmed 1 source | |||
| Smarty Pants Control | 2020-11-25 | Unilever | Undisclosed | Undisclosed | 4.0x | - | - | Confirmed 1 source | ||
| Care/of Control | 2020-08-31 | Bayer | USD 225M | 225 | - | - | United States | Confirmed 1 source | ||
| OLLY Nutrition Control | 2019-04-18 | Unilever | Undisclosed Undisclosed | Undisclosed | 5.0x | 20.0x | United States | Confirmed 1 source | ||
| Nutranext Control | 2018-03-12 | Clorox | USD 700M Consideration | 700 | 3.5x | 14.0x | - | Estimated 1 source | ||
| Atrium Innovations Control | 2017-12-05 | Nestlé | USD 2.3B Consideration | 2,300 | 3.3x | 19.0x | - | Confirmed 1 source | ||
| Nutraceutical Control | 2017-05-22 | HGGC | Undisclosed | Undisclosed | 1.8x | 9.9x | - | Confirmed 1 source | ||
| Swisse Control (3%) | 2015-09-17 | Biostime | USD 1.7B Consideration | 1,670 | - | 15.5x | Australia | Confirmed 1 source | ||
| Schiff Nutrition Control | 2012-11-22 | Reckitt Benckiser | Undisclosed | Undisclosed | 4.2x | 19.1x | - | Confirmed 1 source |
FundComb transaction comps are informational only. Values may be estimated, rumored, incomplete or derived from public information and should not be relied upon as financial, investment or valuation advice.